Sunday, November 22, 2020

Feedburner Hiccups...

For this blog, I use Google's Feedburner to develop the subscription mailing list and send out blog updates.  Only problem is that Feedburner periodically refuses to cooperate with me.  I posted on November 17 and on November 21, but Feedburner skipped most of our subscribers.  

So if you missed those posts, and you're interested in two promising drug trials, you can click these links:

BTW, when you click on a link in an article, it gives the blog a point or so in Google's system, so the blog becomes a little (perhaps very little) more visible on the Internet.

No comments:

Post a Comment

Welcome Kisunla

We reported previously that the FDA's advisory panel had recommended approval of the monoclonal antibody treatment donanemab.  This foll...